CTRI/2021/02/031290招募中4 期
Comparision between phenobarbitone and levetiracetam as the intial anti convulsant in preterm neonatal seizures-a randomized control trail
Gummalla Gyandeep0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Neonate with gestational age <37 week with diagnosis of clinical seizure admitted within 28 days of life in NICU
排除标准
- •Multiple congenital malformation, Seizure secondary to hypoglycemia and hypocalcemia controlled with glucose or calcium bolus respectively
研究者
相似试验
已完成
不适用
A clinical trial to compare the efficacy of phenobarbitone with levetiracetam for the treatment of seizures (fits) in newbornsCTRI/2011/07/001863DR AMIT UPADHYAY60
招募中
3 期
comparison of levetiracetam with phenobarbitone in neonatal seizureCTRI/2013/01/003310I80
招募中
3 期
Comparison of effects of phenobarbital and levetiracetam in neonatal seizure controlIRCT20200528047589N1Mashhad University of Medical Sciences74
尚未招募
1 期
A study to control the effectiveness of two drugs, which are phenobarbitone (used for seizures in first 28 days of life) and levetiracetam ( new drug for seizures) in newborns who have seizures in the first 24 hours of life with delayed cry at birth.CTRI/2020/04/024952Department of neonatology and pediatrics
已完成
2 期
Comparison of phenobarbital and levetiracetam in febrile seizuresFebrile convulsion(F.C).Febrile convulsionsR56.0IRCT20221105056406N1Sabzevar University of Medical Sciences100